Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$159.45
0.0%
$158.45
$94.29
$168.44
$38.06B0.682.23 million shs2.04 million shs
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$108.22
-0.5%
$108.58
$70.78
$119.96
$134.62B0.297.67 million shs6.63 million shs
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
$31.41
$31.37
$14.32
$32.09
$6.32B1.41.23 million shsN/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$107.87
-3.4%
$108.65
$97.80
$126.34
$464.88B0.515.85 million shs32.32 million shs
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
-0.98%-1.52%-3.28%+18.48%+66.11%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
-0.96%-5.01%+0.74%+4.13%+48.43%
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
0.00%0.00%0.00%0.00%0.00%
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
-0.47%-2.78%-2.05%+4.57%-5.03%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
4.8728 of 5 stars
2.44.04.23.63.51.72.5
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
4.893 of 5 stars
1.45.04.24.13.32.53.1
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
N/AN/AN/AN/AN/AN/AN/AN/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
4.9499 of 5 stars
3.35.05.00.03.51.73.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
2.79
Moderate Buy$158.07-0.86% Downside
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
2.77
Moderate Buy$111.382.92% Upside
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
0.00
N/AN/AN/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
2.55
Moderate Buy$125.4216.27% Upside

Current Analyst Ratings Breakdown

Latest TRQ, GILD, CAH, and XOM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/16/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$181.00 ➝ $190.00
7/15/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight
7/11/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
7/11/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Outperform ➝ Sector Outperform$115.00 ➝ $125.00
7/8/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$131.00 ➝ $134.00
7/2/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy$125.00 ➝ $131.00
6/26/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$126.00 ➝ $127.00
6/23/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy$120.00 ➝ $128.00
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price TargetOverweight ➝ Overweight$166.00 ➝ $181.00
6/13/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$157.00 ➝ $170.00
6/12/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$175.00 ➝ $180.00
(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$226.83B0.17$10.43 per share15.29($13.19) per share-12.09
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$28.75B4.68$6.77 per share15.99$15.44 per share7.01
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
$1.97B3.21$3.43 per share9.17$45.27 per share0.69
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$349.59B1.33$12.44 per share8.67$61.57 per share1.75
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$852M$6.4124.8817.821.600.70%-68.84%4.21%8/12/2025 (Estimated)
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$480M$4.7522.7813.340.7120.76%51.93%17.40%8/6/2025 (Estimated)
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
$524.89M$2.7911.26N/A33.00%5.89%3.85%N/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$33.68B$7.5414.3111.962.099.49%12.06%7.21%8/1/2025 (Estimated)

Latest TRQ, GILD, CAH, and XOM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.99N/AN/AN/AN/AN/A
8/12/2025Q4 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.03N/AN/AN/A$60.91 billionN/A
8/1/2025Q2 2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$1.47N/AN/AN/A$79.07 billionN/A
5/2/2025Q1 2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$1.73$1.76+$0.03$1.76$86.11 billion$83.13 billion
5/1/2025Q3 2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.15$2.35+$0.20$2.10$55.33 billion$54.88 billion
4/24/2025Q1 2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$1.77$1.81+$0.04$1.04$6.77 billion$6.67 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
$2.041.28%N/A31.83%29 Years
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
$3.162.92%N/A66.53%10 Years
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
N/AN/AN/AN/AN/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
$3.963.67%N/A52.52%42 Years

Latest TRQ, GILD, CAH, and XOM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/5/2025
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
quarterly$0.51071.35%7/1/20257/1/20257/15/2025
4/22/2025
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
quarterly$0.793%6/13/20256/13/20256/27/2025
5/2/2025
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
quarterly$0.993.74%5/15/20255/15/20256/10/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
N/A
0.94
0.50
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
1.16
1.37
1.23
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
0.35
0.42
0.24
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
0.12
1.24
0.90

Institutional Ownership

CompanyInstitutional Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
87.17%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
83.67%
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
34.39%
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
61.80%

Insider Ownership

CompanyInsider Ownership
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
0.09%
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
0.27%
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
N/A
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
0.03%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cardinal Health, Inc. stock logo
CAH
Cardinal Health
48,900238.68 million238.46 millionOptionable
Gilead Sciences, Inc. stock logo
GILD
Gilead Sciences
17,6001.24 billion1.24 billionOptionable
Turquoise Hill Resources Ltd. stock logo
TRQ
Turquoise Hill Resources
3,478201.23 millionN/AOptionable
Exxon Mobil Corporation stock logo
XOM
Exxon Mobil
61,0004.31 billion4.31 billionOptionable

Recent News About These Companies

Top Hydrogen Stocks To Watch Today - July 18th
Chevron completes $53B Hess takeover after arbitration win over Exxon
Analysts Set Expectations for Exxon Mobil FY2025 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Cardinal Health stock logo

Cardinal Health NYSE:CAH

$159.45 -0.01 (-0.01%)
Closing price 03:59 PM Eastern
Extended Trading
$160.39 +0.94 (+0.59%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Gilead Sciences stock logo

Gilead Sciences NASDAQ:GILD

$108.22 -0.58 (-0.53%)
Closing price 04:00 PM Eastern
Extended Trading
$109.00 +0.78 (+0.72%)
As of 06:18 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

Turquoise Hill Resources stock logo

Turquoise Hill Resources NYSE:TRQ

Turquoise Hill Resources Ltd., together with its subsidiaries, operates as a mining company. The company primarily explores for copper, gold, and silver deposits. It engages in the operation and development of the Oyu Tolgoi copper-gold mine located in Southern Mongolia. The company was formerly known as Ivanhoe Mines Ltd. and changed its name to Turquoise Hill Resources Ltd. in August 2012. Turquoise Hill Resources Ltd. was incorporated in 1994 and is headquartered in Montreal, Canada. Turquoise Hill Resources Ltd. operates as a subsidiary of Rio Tinto Group.

Exxon Mobil stock logo

Exxon Mobil NYSE:XOM

$107.87 -3.79 (-3.39%)
Closing price 03:59 PM Eastern
Extended Trading
$107.73 -0.14 (-0.13%)
As of 06:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Exxon Mobil Corporation engages in the exploration and production of crude oil and natural gas in the United States and internationally. It operates through Upstream, Energy Products, Chemical Products, and Specialty Products segments. The Upstream segment explores for and produces crude oil and natural gas. The Energy Products segment offers fuels, aromatics, catalysts, and licensing services. It sells its products under the Exxon, Esso, and Mobil brands. The Chemical Products segment manufactures and markets petrochemicals, including olefins, polyolefins, and intermediates. The Specialty Products segment offers performance products, including lubricants, basestocks, waxes, synthetics, elastomers, and resins. The company is also involved in the manufacturing, trade, transport, and selling crude oil, natural gas, petroleum products, petrochemicals, and other specialty products in pursuit of lower-emission business opportunities, including carbon capture and storage, hydrogen, lower-emission fuels, and lithium. Exxon Mobil Corporation was founded in 1870 and is based in Spring, Texas.